Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2025-12-25 @ 9:03 PM
Study NCT ID:
NCT07011056
Status:
RECRUITING
Last Update Posted:
2025-09-19
First Post:
2025-05-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma
Sponsor:
Chengdu Zenitar Biomedical Technology Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-18
Start Date Type:
ACTUAL
Primary Completion Date:
2029-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-30
First Submit QC Date:
None
Study First Post Date:
2025-06-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-15
Last Update Post Date:
2025-09-19
Last Update Post Date Type:
ESTIMATED